| Participant Tracking and Tracing in the PLCO and NLST/LSS Trials |
Pamela Marcus |
National Cancer Institute |
NLST |
Jun 22, 2009 |
200906-0040 |
| Participant Tracking and Tracing in the PLCO and NLST/LSS Trials |
Pamela Marcus |
NCI, DCP, BRG |
PLCO |
Aug 13, 2009 |
2009-0159 |
| Patient Factors Associated with A Positive Finding on First CT Screening Exam |
Alex Balekian |
University of Southern California |
NLST |
Jun 6, 2014 |
NLST-76 |
| Patient management from lung screening to diagnosis |
Sean Denham |
Canon Medical Research Europe |
NLST |
Aug 8, 2023 |
NLST-1102 |
| Patient Satisfaction with Screening: Flexible Sigmoidoscopy |
Robert Schoen |
University of Pittsburgh |
PLCO |
Jul 1, 2006 |
2006-0232 |
| Patterns of Care and Outcomes for Prostate Cancer in the United States |
Paul Nguyen |
Brigham and Women's Hospital |
PLCO |
Aug 17, 2015 |
PLCO-149 |
| Patterns of Follow-up Evaluation for Positive Screening Exams |
Mona Fouad |
University of Alabama at Birmingham |
PLCO |
Jul 1, 2006 |
2006-0092 |
| PCOS proposal: Ultrasound Appearance of Post menopausal Ovaries as a Marker of Increased Risk for Endometrial, Breast, and Colorectal Cancer |
Mark Sherman |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0160 |
| Perception of Discomfort During Sigmoidoscopic Examination |
Timothy Church |
University of Minnesota |
PLCO |
Jul 1, 2006 |
2006-0057 |
| Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States |
Xuehong Zhang |
Harvard Medical School and Brigham and Women's Hospital |
PLCO |
Dec 22, 2020 |
2020-1001 |
| Perfluorooctanoic acid (PFOA) exposure, DNA methylation patterns, and renal cell carcinoma |
Charles Breeze |
National Cancer Institute |
PLCO |
Jan 19, 2023 |
2022-0036 |
| Performance evaluation and generalisability of an AI algorithm for lung cancer detection |
Lizzie Barclay |
Annalise-AI Pty Ltd |
PLCO |
May 30, 2023 |
PLCOI-1234 |
| Performance Evaluation of Colorectal Cancer Diagnosis Classification using Machine Learning Algorithms. |
HYUNJIN KWON |
Open Convergence Lab |
PLCO |
Sep 28, 2018 |
PLCO-399 |
| Personalised lung cancer treatment through outcome predictions and patient stratification |
Charles-Antoine Collins Fekete |
University College London |
NLST |
Feb 16, 2022 |
NLST-881 |
| Personalized Dynamic Risk-based Lung Cancer Screening |
Sylvia Plevritis |
Stanford University |
NLST |
Aug 30, 2018 |
NLST-438 |
| Personalized Medicine: A New Paradigm of Decision Support for Pulmonary Nodules Using the National Lung Screening Trial Dataset |
James Morrison |
University of Maryland |
NLST |
Sep 12, 2013 |
NLST-35 |
| Personalized Risk Information in Cost Effectiveness Studies (PRICES) |
David Kent |
Tufts Medical Center |
NLST |
Jan 10, 2014 |
NLST-47 |
| Personalizing colorectal treatment strategies through machine learning |
Jean-Emmanuel Bibault |
Stanford University |
PLCO |
Feb 27, 2020 |
PLCO-592 |
| Personalizing Lung Cancer Screening for Smokers with Comorbidities |
Minal Kale |
Icahn School of Medicine at Mount Sinai |
PLCO |
Feb 7, 2020 |
PLCO-578 |
| Personalizing screening intervals for lung cancer screening using artificial intelligence |
Scott Adams |
University of Saskatchewan |
NLST |
May 30, 2023 |
NLST-1064 |
